Thomas A. Jr Medsger
#99,188
Most Influential Person Now
Thomas A. Jr Medsger's AcademicInfluence.com Rankings
Thomas A. Jr Medsgerphilosophy Degrees
Philosophy
#3822
World Rank
#6113
Historical Rank
Logic
#1436
World Rank
#2187
Historical Rank

Download Badge
Philosophy
Why Is Thomas A. Jr Medsger Influential?
(Suggest an Edit or Addition)Thomas A. Jr Medsger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. (1988) (3914)
- Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. (1980) (3058)
- 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. (2013) (2731)
- Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. (1997) (1767)
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative (2013) (1713)
- Criteria for the classification of early systemic sclerosis. (2001) (1319)
- Changes in causes of death in systemic sclerosis, 1972–2002 (2007) (1305)
- Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease (2000) (1084)
- Severe organ involvement in systemic sclerosis with diffuse scleroderma. (2000) (876)
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. (1988) (571)
- Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. (1989) (543)
- Severe restrictive lung disease in systemic sclerosis. (1994) (515)
- Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. (2003) (496)
- The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. (1997) (437)
- A disease severity scale for systemic sclerosis: development and testing. (1999) (436)
- Mortality in systemic sclerosis: an international meta-analysis of individual patient data. (2005) (435)
- Incidence of systemic lupus erythematosus. Race and gender differences. (1995) (432)
- Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial (2010) (426)
- Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. (1998) (417)
- Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. (1990) (415)
- A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. (1982) (380)
- Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study (1994) (379)
- Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. (1986) (373)
- Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. (1984) (372)
- Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. (1980) (365)
- Assessment of disease severity and prognosis. (2003) (349)
- Myeloablative Autologous Stem‐Cell Transplantation for Severe Scleroderma (2018) (344)
- Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. (1971) (332)
- Adult-onset Still's disease. Clinical course and outcome. (1987) (327)
- A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. (1982) (319)
- Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. (2002) (311)
- High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. (1999) (307)
- Predictors of survival in systemic sclerosis (scleroderma). (1991) (305)
- D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. (1982) (304)
- Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. (1995) (301)
- Long-Term Outcomes of Scleroderma Renal Crisis (2000) (288)
- The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. (1998) (284)
- Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. (2003) (274)
- Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. (2000) (272)
- Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis (2017) (264)
- Epidemiology of systemic sclerosis (scleroderma). (1971) (254)
- Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. (1984) (252)
- Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. (1987) (251)
- Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. (1984) (250)
- Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. (2000) (248)
- Classification criteria for the idiopathic inflammatory myopathies. (1997) (243)
- Raynaud's phenomenon: a proposal for classification. (1992) (243)
- Isolated diffusing capacity reduction in systemic sclerosis. (1992) (237)
- The epidemiology of polymyositis. (1970) (236)
- Improvement in skin thickening in systemic sclerosis associated with improved survival. (2001) (231)
- Factors predicting development of renal involvement in progressive systemic sclerosis. (1984) (221)
- Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. (1984) (220)
- Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. (2002) (220)
- Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis: REVIEW OF A 25‐YEAR EXPERIENCE WITH 68 CASES (1983) (218)
- The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. (1967) (217)
- Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. (2003) (212)
- Autoantibody Reactive with RNA Polymerase III in Systemic Sclerosis (1993) (212)
- Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. (1990) (211)
- Cancer and systemic sclerosis. An epidemiologic study. (1985) (210)
- Normotensive renal failure in systemic sclerosis. (1989) (207)
- Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma (2010) (203)
- Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). (1988) (197)
- Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. (1992) (197)
- Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. (1993) (194)
- Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. (1994) (189)
- Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. (1998) (188)
- Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. (1992) (178)
- Eosinophilic fasciitis. A pathologic study of twenty cases. (1979) (178)
- Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. (1986) (177)
- A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. (2003) (176)
- Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. (1997) (174)
- Pulmonary involvement in systemic sclerosis (scleroderma). (1985) (174)
- The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. (2007) (163)
- Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. (2003) (162)
- Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. (2006) (162)
- A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). (1990) (161)
- Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. (2010) (160)
- Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. (2005) (153)
- Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. (1999) (147)
- Palmar fasciitis and polyarthritis associated with ovarian carcinoma. (1982) (146)
- Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. (1986) (146)
- Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome (1986) (144)
- Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. (2006) (142)
- Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study (2006) (141)
- Factors affecting survivorship in polymyositis. A life-table study of 124 patients. (1971) (140)
- Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (2014) (137)
- Anti-U3 RNP autoantibodies in systemic sclerosis. (2009) (135)
- Prognostic importance of cardiac arrhythmias in systemic sclerosis. (1988) (135)
- Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. (1983) (133)
- Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. (2007) (133)
- A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. (2012) (133)
- Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. (2009) (129)
- Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. (2007) (127)
- Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. (1996) (125)
- Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. (1994) (125)
- Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. (2009) (123)
- Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. (1973) (122)
- Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). (1968) (120)
- Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. (1994) (115)
- Epidemiology and natural history of systemic sclerosis. (1990) (115)
- Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. (1999) (115)
- The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures (2009) (114)
- Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study (2004) (114)
- Fertility and pregnancy outcome in women with systemic sclerosis. (1999) (112)
- Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. (2013) (109)
- Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. (2009) (109)
- Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. (2009) (108)
- Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. (1990) (107)
- Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). (1988) (107)
- Kidney disease other than renal crisis in patients with diffuse scleroderma. (2005) (107)
- The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. (2001) (105)
- Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials (2013) (104)
- T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. (1995) (101)
- Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. (1985) (101)
- Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. (1987) (100)
- Carpal arthritis with ankylosis in late onset Still's disease. (1976) (99)
- Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. (1981) (97)
- The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. (1985) (97)
- D-penicillamine in the treatment of localized scleroderma. (1990) (96)
- A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. (1990) (93)
- Approaches for identifying and defining environmentally associated rheumatic disorders. (2000) (92)
- Trigeminal neuropathy in progressive systemic sclerosis. (1982) (92)
- Antiphospholipid antibodies in pediatric systemic lupus erythematosus. (1995) (91)
- Validation of potential classification criteria for systemic sclerosis (2012) (90)
- Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. (2005) (90)
- Serum Autoantibodies and Their Clinical Associations in Patients with Childhood- and Adult-Onset Linear Scleroderma. A Single-Center Study (2008) (86)
- Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. (1987) (86)
- A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. (1995) (86)
- The effect of D-penicillamine on pulmonary findings in systemic sclerosis. (1985) (85)
- Proceedings: Eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. (1975) (85)
- Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). (1996) (85)
- Scleroderma Renal Crisis: A Pathology Perspective (2010) (84)
- The palpable tendon friction rub (1997) (83)
- The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. (1997) (83)
- Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. (1991) (83)
- Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. (1988) (82)
- T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. (1995) (81)
- Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA (1995) (81)
- Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. (1996) (81)
- Renal biopsy findings predicting outcome in scleroderma renal crisis. (2009) (80)
- Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes (2016) (80)
- Treatment of systemic sclerosis with recombinant interferon‐γ. A phase I/II clinical trial (1992) (78)
- Pregnancy in women with systemic sclerosis. (1989) (76)
- Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. (2014) (76)
- The toxicity of D-penicillamine in systemic sclerosis. (1986) (75)
- Cytokine production and serum levels in systemic sclerosis. (1992) (75)
- Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. (1996) (73)
- Risk of malignancy in women with systemic lupus erythematosus. (1995) (73)
- Anti-PM-Scl antibody in patients with systemic sclerosis. (2012) (73)
- Surgery for scleroderma of the hand. (1987) (71)
- The rheumatic manifestaions of progressive systemic sclerosis (scleroderma). (1968) (70)
- Coronary arteritis in systemic lupus erythematosus. (1976) (70)
- Localization of Ro (SS-A) antigen in the cardiac conduction system. (1987) (68)
- Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. (1993) (67)
- Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. (1997) (67)
- Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. (1989) (66)
- Herpes zoster in systemic lupus erythematosus. (1995) (65)
- Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. (2016) (64)
- Outcome measurements in scleroderma: results from a delphi exercise. (2007) (64)
- Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. (2014) (62)
- Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. (2007) (61)
- Epidemiology of progressive systemic sclerosis (1979) (61)
- Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise (2012) (60)
- Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III. (1993) (60)
- Vasculitis in systemic sclerosis: association with Sjögren's syndrome and the CREST syndrome variant. (1987) (60)
- Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. (1994) (58)
- Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. (2015) (58)
- Hypocalcemia associated with metastatic bone disease. A retrospective study. (1973) (57)
- Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis (1990) (57)
- Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary? (1985) (57)
- Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. (2010) (57)
- Alpha1‐antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis (1986) (57)
- The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. (1978) (56)
- Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). (1986) (56)
- Systemic sclerosis secondary to occupational exposure. (1988) (55)
- Systemic sclerosis (scleroderma) and multiple sclerosis. (1986) (55)
- Assessment of damage and activity in systemic sclerosis (2000) (54)
- A controlled study of the long-term prognosis of adult Still's disease. (1995) (53)
- Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. (2005) (53)
- High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. (2004) (53)
- Hydralazine induced lupus and Sweet's syndrome. Report and review of the literature. (1990) (52)
- Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. (2012) (51)
- Tryptophan-induced eosinophilia-myalgia syndrome. (1990) (51)
- Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. (1984) (51)
- GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. (2011) (51)
- High titers of antibodies to single-stranded DNA in linear scleroderma. (1985) (50)
- Serum antibody to retroviral gag proteins in systemic sclerosis. (1991) (50)
- Immune complexes in progressive systemic sclerosis (scleroderma). (1982) (49)
- Clinical and serological features of systemic sclerosis in a multicenter African American cohort (2017) (49)
- Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis. (1986) (49)
- Treatment of systemic sclerosis. (1989) (49)
- Factors Predicting Development of Renal Involvement in Progressive Systemic Sclerosis (1984) (48)
- Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. (2000) (48)
- Consensus statement on the relationship of breast implants to connective-tissue disorders. (1992) (48)
- Treatment of systemic sclerosis. (1989) (47)
- Epidemiology of systemic sclerosis. (1994) (46)
- Skin-Resident Effector Memory CD8+CD28- T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis. (2017) (45)
- Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. (2001) (45)
- Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin). (2000) (44)
- Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. (1982) (43)
- Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. (1993) (43)
- Soluble serum interleukin 2 receptors in patients with systemic sclerosis. (1996) (42)
- Systemic sclerosis (scleroderma) (1991) (42)
- HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies. (1998) (42)
- Cerebrospinal fluid immune complexes in systemic lupus erythematosus involving the central nervous system. (1982) (41)
- Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen. (1988) (40)
- Risk factors for adult Still's disease. (1996) (40)
- Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis. (1988) (39)
- Conclusion and identification of the core set of variables to be used in clinical investigations. (2003) (39)
- HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry (2019) (38)
- Significance of Palpable Tendon Friction Rubs in Early Diffuse Cutaneous Systemic Sclerosis (2013) (38)
- Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts. (1989) (38)
- Scleromyxedema myopathy: case report and review of the literature. (1988) (37)
- Derivation and Validation of a Prediction Rule for Two‐Year Mortality in Early Diffuse Cutaneous Systemic Sclerosis (2014) (36)
- Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes. (1999) (36)
- An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera. (1999) (35)
- Previous Pregnancy Outcome Is an Important Determinant of Subsequent Pregnancy Outcome in Women With Systemic Lupus Erythematosus (1992) (35)
- Analysis of Soluble and Cell Surface Factors Regulating Anti-DNA Topoisomerase I Autoantibody Production Demonstrates Synergy Between Th1 and Th2 Autoreactive T Cells1 (2000) (35)
- Progressive systemic sclerosis. (1983) (35)
- Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases. (2001) (35)
- The assessment of the patient with systemic sclerosis. Introduction. (2003) (34)
- Allergic granulomatous angiitis (Churg-Strauss syndrome). (1975) (34)
- Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis (2013) (33)
- HLA-DR antigens in progressive systemic sclerosis (scleroderma). (1983) (32)
- Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides. (1995) (32)
- HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. (1995) (32)
- Microsurgical revascularisation of the hand in scleroderma. (1987) (31)
- Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Randomized, Placebo-controlled Trial. (2021) (29)
- Circulating immune complexes in eosinophilic fasciitis. (1982) (29)
- Communicating hydrocephalus secondary to diffuse meningeal spread of Wegener's granulomatosis: case report and literature review. (1998) (28)
- Resorption of the mandibular condyles and coronoid processes in progressive systemic sclerosis (scleroderma). (1981) (28)
- Anemia and scleroderma: frequency, causes, and marrow findings. (1968) (27)
- Anti–RNPC‐3 (U11/U12) Antibodies in Systemic Sclerosis in Patients With Moderate‐to‐Severe Gastrointestinal Dysmotility (2019) (24)
- A new look at the epidemiology of ankylosing spondylitis and related syndromes. (1979) (24)
- Newly identified U4/U6 snRNP-binding proteins by serum autoantibodies from a patient with systemic sclerosis. (1991) (23)
- Study of 102 Consecutive Cases with Functional Correlations and Review of the Literature (1985) (23)
- Brachial plexitis mimicking C5 radiculopathy--a presentation of giant cell arteritis. (1983) (22)
- Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets (2019) (22)
- Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. (1986) (22)
- T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I. (2006) (20)
- Myasthenia gravis and scleroderma: Two cases and a review of the literature (2007) (20)
- 1972-2002in causes of death in systemic sclerosis, (2007) (20)
- Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. (2017) (20)
- Quality indicator set for systemic sclerosis. (2011) (20)
- Molecular Recognition Patterns of Serum Anti-DNA Topoisomerase I Antibody in Systemic Sclerosis1 (2004) (20)
- Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial. (1992) (20)
- Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry (2018) (19)
- L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak. (1992) (19)
- Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. (1996) (19)
- Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis. (1992) (18)
- Autoantibodies and Their Role in Scleroderma Clinical Care (2016) (18)
- Reduced natural killer cell activity in patients with systemic sclerosis. Correlation with clinical disease type. (1988) (18)
- Photopheresis for scleroderma? No! (1992) (18)
- Disease Subsets in Clinical Practice (2012) (18)
- Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma). (1984) (17)
- 14‐3‐3z sequesters cytosolic T‐bet, upregulating IL‐13 levels in TC2 and CD8+ lymphocytes from patients with scleroderma (2017) (17)
- Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis. (1985) (17)
- Serum eosinophilotactic activity in eosinophilic fasciitis. (1982) (17)
- D-penicillamine in systemic sclerosis? Yes! (2001) (16)
- Progress in the Evolution of Systemic Sclerosis Classification Criteria and Recommendation for Additional Comparative Specificity Studies (2015) (15)
- D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma). (1987) (15)
- Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA. (1992) (15)
- Classification and diagnostic criteria for polymyositis and dermatomyositis. (1995) (14)
- Brief Report: HLA–DRB1, DQA1, and DQB1 in Juvenile‐Onset Systemic Sclerosis (2016) (14)
- Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. (2001) (14)
- Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis. (1982) (13)
- Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival (2019) (13)
- Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma) (1982) (13)
- Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome. (2001) (13)
- The future status of pediatric rheumatology in the United States: strategic planning for the year 2000. American College of Rheumatology Blue Ribbon Committee for Academic Pediatric Rheumatology. (2000) (12)
- Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis (2021) (12)
- The variability of immunologic laboratory tests. (1982) (12)
- Localized scleroderma and regional inflammatory myopathy (2014) (11)
- Wrist drop in progressive systemic sclerosis (scleroderma): complete rupture of the extensor tendon mechanism. (1985) (11)
- Severe arthralgias after wide fluctuation in corticosteroid dosage. (1986) (10)
- Identification of Autoantibodies to RNA Polymerase 11 Occurrence in Systemic Sclerosis and Association with Autoantibodies to RNA Polymerases (2013) (10)
- Discordance of SSA/Ro and SSB/La cellular antigens in synchronized cells. (1986) (10)
- History of skin thickness assessment and the Rodnan skin thickness scoring method in systemic sclerosis (2019) (10)
- Serum immunoglobulins, rheumatoid factor, and pneumoconiosis in coal miners with rheumatoid arthritis. (1976) (9)
- Brief Report: Whole‐Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans (2018) (9)
- Rationale for and efficacy of digital arterial reconstruction in scleroderma: report of two cases. (2002) (9)
- Muscle cramps associated with localized scleroderma skin lesions: focal dystonia, neuromyotonia, or nerve entrapment? (2006) (9)
- Cholestasis associated with D-penicillamine therapy: case report and review of the literature. (1981) (8)
- IL-13-producing CD 8 + T cells mediate dermal fibrosis in patients with systemic sclerosis (2013) (7)
- A Novel Protein Highly Expressed in Testis Is Overexpressed in Systemic Sclerosis Fibroblasts and Targeted by Autoantibodies 1 (2003) (7)
- Lipid microspherule-associated acute monarticular arthritis. (1986) (7)
- Over one-third of Th/To antibody positive scleroderma patients develop pulmonary hypertension in long-term follow-up. (2022) (7)
- Systemic sclerosis and malignancy--are they related? (1985) (7)
- Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed (2011) (7)
- Preliminary classification criteria for systemic sclerosis in children. (2005) (7)
- The Association of Progressive Systemic Sclerosis (Sclerodenna) with Coal Miners?? Pneumoeoniosis and Other Forms of Silicosis (1967) (6)
- Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. (2021) (6)
- Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension (2019) (6)
- Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion. (1987) (5)
- Proceedings: HL-A antigen 27 and psoriatic spondylitis. (1974) (5)
- Elevated serum soluble interleukin-2 receptor levels in subacute cutaneous lupus erythematosus. (1993) (5)
- Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements. (1994) (5)
- rheumatism collaborative initiative rheumatology / European league against sclerosis : an American college of 2013 classification criteria for systemic (2013) (4)
- RNA Polymerase I-III Autoantibodies (1996) (4)
- Localized Expression of Tenascin in Systemic Sclerosis-Associated Lung Fibrosis and its Regulation by IGF Binding Protein (IGFBP)-3 (2012) (4)
- A novel cell-cycle-dependent 350-kDa nuclear protein: C-terminal domain sufficient for nuclear localization. (1995) (4)
- Minimally Important Difference in Diffuse Systemic Sclerosis (2006) (3)
- The Clinical Aspects of Autoantibodies (2017) (3)
- The Frequency of the Rheumatic Diseases (1972) (3)
- Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets (2019) (3)
- We need simple guidelines for reporting rates of rheumatic diseases. (1999) (2)
- Two Scleroderma Patients with Differing Patterns of Muscle Disease (2011) (2)
- Synergy Between Th 1 and Th 2 Autoreactive Autoantibody Production Demonstrates Regulating Anti-DNA Topoisomerase I Analysis of Soluble and Cell Surface Factors (2000) (2)
- The Lupus Foundation as an additional source for case ascertainment: developing a community-based lupus registry. (2000) (2)
- Response of patients with renal involvement by progressive systemic sclerosis to antihypertensive therapy. (1981) (2)
- Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA. (1987) (2)
- Hematopoietic Stem Cell Transplantation for Systemic Sclerosis (2019) (2)
- Sjögren’s Syndrome and Systemic Sclerosis (Scleroderma) (1987) (2)
- Treatment of systemic sclerosis. (1989) (1)
- Development of Pulmonary Hypertension in Over One‐Third of Patients With Th/To Antibody–Positive Scleroderma in Long‐Term Follow‐Up (2022) (1)
- AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach (2015) (1)
- Treatment of systemic sclerosis. (1990) (1)
- Current Management of Polymyositis and Dermatomyositis (1989) (1)
- Commentary on myofascial release therapy in systemic lupus erythematosus and scleroderma. (2012) (1)
- Gastric Antral Vascular Ectasia in Scleroderma: A Single Center Experience (2011) (1)
- A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials. (2022) (1)
- Scleroderma renal crisis: a high index of suspicion speeds diagnosis and life-saving treatment. (2006) (1)
- Systemic Sclerosis (Scleroderma) and Raynaud’s Phenomenon (2009) (1)
- Natural killer cell numbers in systemic sclerosis (1987) (0)
- Personalized Gene Expression Profile Information Predicts Severity of Systemic Sclerosis Despite Heterogeneity of Disease (2018) (0)
- The diffuse form of scleroderma is associated with DRB1 1104 (1991) (0)
- Analysis of T-Cell Repertoire before and 21 Days after Autologous Peripheral Blood Stem Cell Transplantation for Systemic Sclerosis. (2004) (0)
- Gerald P. Rodnan, 1927–1983 (1984) (0)
- Fibroblasts and Targeted by Autoantibodies Overexpressed in Systemic Sclerosis A Novel Protein Highly Expressed in Testis Is (2003) (0)
- Reply to Andréasson et al.: Multiple Manifestations of Systemic Sclerosis Affect Walk Distance (2021) (0)
- Case report Myasthenia gravis and scleroderma: Two cases and a review of the literature (2007) (0)
- 3420 Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival (2019) (0)
- Reply (2017) (0)
- Inflammatory myopathies. (1995) (0)
- Survival with Systemic Sclerosis (Scleroderma) (2020) (0)
- AB0840 Scleroderma classification criteria: Disease-specific methods for valid case comparisons (2013) (0)
- 19 – Enfermedades reumatológicas (2007) (0)
- Lead Authors and Contributors (2010) (0)
- Systemic Sclerosis Anti-DNA Topoisomerase I Antibody in Molecular Recognition Patterns of Serum (2004) (0)
- Intensive Immunosuppression Plus T-Cell Depleted Autologous Peripheral Blood Stem Cell Transplantation for Systemic Sclerosis. (2004) (0)
- Discrepancies betweenin vivo andin vitro responses toCandida antigen in patients with progressive systemic sclerosis (PSS; scleroderma) (1981) (0)
- HLA contributions to risk and protection for anti-centromere autoantibody-positive scleroderma (2018) (0)
- Molecular aspects of IL-13 up-regulation by CD8+ T cells from systemic sclerosis patients (BA3P.132) (2014) (0)
- Reply for “Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients with Early Diffuse Cutaneous Scleroderma” (2016) (0)
- The Journal of Rheumatology Localized Scleroderma Outcome Measures Assessment of Disease Activity: A Work in Progress Toward Development of The Localized Scleroderma Skin Severity Index and Physician Global (2009) (0)
- Dr Leroy's contribution to the understanding of systemic sclerosis. (2004) (0)
- Clinical and Serologic Patients Subsets in Scleroderma(第167回北里医学会招待学術講演会要旨) (1992) (0)
- NUCLEOLAR ANTIGEN PM-Scl (2005) (0)
- Proceedings: Selective carpo-metacarpal arthritis with early ankylosis in adult onset Still's disease. (1975) (0)
- Hypocalcemia Associated With Metastatic Bone Disease (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas A. Jr Medsger?
Thomas A. Jr Medsger is affiliated with the following schools: